MATTHEW PALMER, OD
Optometrist in MESA, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MATTHEW PALMER, OD reported a CMS MIPS final score of 87.6527/100 — above the 83.1 national average — and filed 2,382 Medicare Part D claims in 2023.
- 87.6527/100
- MIPS score · +5 vs avg
- 2K
- Part D claims, 2023
- 44%
- generic prescribing
- $1.5K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MATTHEW PALMER, OD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
88 Top 46% higher than 54% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about MATTHEW PALMER, OD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Arizona
How Optometrist compares to other specialties among Arizona providers
Optometrist share within Arizona
Optometrist is one of the more visible NUCC categories in Arizona
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MATTHEW PALMER, OD's 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 87.6527/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) — 87.6527/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Optometrist US NPIs
87.6527/100 MIPS final score — 4.6 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 100. Cost dim: 58.8423.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MATTHEW PALMER, OD appears in the CMS NPPES registry as a Optometrist provider holding OD credentials at 1055 S STAPLEY DR, MESA, AZ, 85204, with a listed phone of (480) 833-9100. NPI 1093970931 was issued on 07/21/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PALMER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,382 prescription claims written by this provider, covering 564 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, split 56% brand-name and 44% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 87.6527/100 for the 2023 performance year (Quality 100, Cost 58.8423), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1093970931 |
|---|---|
| Specialty | Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 07/21/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MATTHEW PALMER, OD's current license status, disciplinary history, and board certifications with the Arizona Medical Board in Arizona before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where MATTHEW PALMER, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW PALMER, OD. Source: openpaymentsdata.cms.gov.
Total received
$1.5K
Largest payer
ANI Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
56% brand-name claims vs 44% generic, on 2,382 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,017
- Total Day Supply
- 112,964
- Brand vs Generic
- 56% brand / 44% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $37K
- Antibiotic Claims
- 46
Patient Demographics
- Average Patient Age
- 74.7 years
- Avg HCC Risk Score
- 1.43
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 62, 65-74: 212, 75-84: 197, 85+: 93
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MATTHEW PALMER, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
489 claims
- Prednisolone Acetate
Prednisolone Acetate
250 claims
- Timolol Maleate
Timolol Maleate
241 claims
- Lumigan
Lumigan
201 claims
- Ciprofloxacin Hcl 177
Ciprofloxacin Hcl
177 claims
- Restasis 140
Restasis
140 claims
- Doxycycline Hyclate 62
Doxycycline Hyclate
62 claims
- Xiidra 54
Xiidra
54 claims
| Drug | Claims |
|---|---|
| Latanoprost | 489 |
| Prednisolone Acetate | 250 |
| Timolol Maleate | 241 |
| Lumigan Bimatoprost | 201 |
| Ciprofloxacin Hcl | 177 |
| Restasis Cyclosporine | 140 |
| Doxycycline Hyclate | 62 |
| Xiidra Lifitegrast | 54 |
| Tobramycin | 52 |
| Alrex Loteprednol Etabonate | 51 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How MATTHEW PALMER, OD fits within the Optometrist landscape nationally.
MATTHEW PALMER, OD's 2,382 claims are above the specialty average of 257.
Nearby Optometrist Providers in Arizona
Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as PALMER.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Arizona
Frequently Asked Questions
What is MATTHEW PALMER, OD's specialty? ▼
How much does MATTHEW PALMER, OD prescribe under Medicare Part D? ▼
What is MATTHEW PALMER, OD's Medicare quality score? ▼
Where is MATTHEW PALMER, OD located? ▼
What is MATTHEW PALMER, OD's NPI number? ▼
Does MATTHEW PALMER, OD prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does MATTHEW PALMER, OD prescribe most often? ▼
Does MATTHEW PALMER, OD accept Medicare? ▼
How can I verify MATTHEW PALMER, OD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology